Skip to main content
. 2018 Feb 23;11(2):467–476. doi: 10.1016/j.tranon.2018.02.001

Figure 1.

Figure 1

(A) Normalized marker gene expression distributed by gender. (B) Normalized maker gene expression and respective cut-off levels defined by participation analyses. (C) Overall expression of the four marker genes. (D) Percentage of patients/tumors defined as positive or negative by the respective marker gene expression based-stratification. (E) Number of patients allocated to the four breast cancer subtypes.